Fresenius Kabi

FDA
MedTech

Fresenius Kabi faces another Class I infusion pump recall

For the third time since 2022, Fresenius Kabi has earned a Class I rating from the FDA for a recall of its Ivenix medication delivery technology.
Andrea Park Jan 16, 2024 12:45pm
FDA stop sign

Fresenius Kabi recalls newly acquired infusion pump system

Apr 20, 2023 10:29am
drug delivery

Fresenius Kabi nabs smart infusion pump maker Ivenix for $240M

Mar 31, 2022 12:36pm